Clinical Trial Update: A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating long-term safety and efficacy of Tenapanor alone or with Sevelamer in dialysis patients with hyperphosphatemia and end-stage renal dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Sevelamer (sevelamer hydrochloride)
• Tenapanor (tenapanor)

Snippet

Sponsor: Ardelyx | Conditions: Hyperphosphatemia, End Stage Renal Disease | Phase 4 | Status: COMPLETED | Results posted: 2023-03-29